Bristol-Myers Squibb Co (BMY)
58.16
+0.28
(+0.48%)
USD |
NYSE |
Nov 21, 15:45
Bristol-Myers Squibb Price: 58.16 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 58.60 | 58.83 | 57.67 | 57.88 | 10.59M |
| Nov 19, 2024 | 56.50 | 58.65 | 56.10 | 58.23 | 13.13M |
| Nov 18, 2024 | 56.18 | 56.84 | 55.84 | 56.80 | 10.71M |
| Nov 15, 2024 | 58.16 | 58.36 | 55.82 | 56.22 | 21.26M |
| Nov 14, 2024 | 58.91 | 59.73 | 58.26 | 58.50 | 11.49M |
| Nov 13, 2024 | 59.21 | 59.49 | 57.84 | 58.41 | 11.21M |
| Nov 12, 2024 | 59.82 | 60.62 | 58.81 | 59.02 | 15.14M |
| Nov 11, 2024 | 60.72 | 61.08 | 59.53 | 59.82 | 27.90M |
| Nov 08, 2024 | 54.70 | 54.78 | 53.97 | 54.14 | 9.219M |
| Nov 07, 2024 | 55.19 | 55.52 | 54.49 | 54.71 | 12.04M |
| Nov 06, 2024 | 56.34 | 56.80 | 55.14 | 55.28 | 11.78M |
| Nov 05, 2024 | 55.14 | 56.28 | 54.72 | 55.95 | 9.278M |
| Nov 04, 2024 | 54.33 | 55.77 | 54.32 | 55.45 | 10.81M |
| Nov 01, 2024 | 55.88 | 55.90 | 54.20 | 54.32 | 12.89M |
| Oct 31, 2024 | 53.80 | 56.20 | 53.56 | 55.77 | 18.74M |
| Oct 30, 2024 | 52.50 | 53.15 | 52.29 | 52.66 | 9.654M |
| Oct 29, 2024 | 52.34 | 52.74 | 52.14 | 52.50 | 8.372M |
| Oct 28, 2024 | 51.95 | 52.76 | 51.81 | 52.64 | 8.529M |
| Oct 25, 2024 | 52.68 | 52.90 | 51.82 | 51.92 | 7.127M |
| Oct 24, 2024 | 52.90 | 53.40 | 52.42 | 52.92 | 7.103M |
| Oct 23, 2024 | 52.80 | 53.11 | 52.54 | 53.06 | 5.833M |
| Oct 22, 2024 | 52.03 | 53.06 | 52.03 | 52.76 | 7.123M |
| Oct 21, 2024 | 53.28 | 53.30 | 52.10 | 52.12 | 5.353M |
| Oct 18, 2024 | 53.26 | 53.33 | 52.34 | 53.22 | 7.184M |
| Oct 17, 2024 | 53.19 | 53.58 | 52.83 | 53.18 | 7.949M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
39.66
Minimum
Jul 05 2024
81.13
Maximum
Dec 02 2022
61.83
Average
62.14
Median
Feb 25 2020
Price Benchmarks
| Johnson & Johnson | 155.73 |
| Eli Lilly and Co | 746.28 |
| Merck & Co Inc | 99.94 |
| Pfizer Inc | 25.04 |
| AbbVie Inc | 171.90 |
Price Related Metrics
| PS Ratio | 2.488 |
| Price to Book Value | 6.881 |
| Price to Free Cash Flow | 8.549 |
| Earnings Yield | -6.17% |
| Market Cap | 117.96B |
| Operating PE Ratio | 16.21 |
| Normalized PE Ratio | 36.43 |